| PERIOD ENDING | 4-Apr-09 | 3-Jan-09 | 4-Oct-08 | 5-Jul-08 | | Total Revenue | 779,665 | 911,173 | 985,470 | 966,761 | | Cost of Revenue | 430,842 | 495,288 | 487,533 | 508,210 | | | Gross Profit | 348,823 | 415,885 | 497,937 | 458,551 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 425,029 | 448,683 | 458,703 | 481,673 | | Non Recurring | 1,898 | 683,071 | 10,046 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (78,104) | (715,869) | 29,188 | (23,122) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,913 | (3,749) | 797 | (924) | | Earnings Before Interest And Taxes | (72,191) | (719,618) | 29,985 | (24,046) | | Interest Expense | 13,882 | 14,366 | 12,049 | 9,770 | | Income Before Tax | (86,073) | (733,984) | 17,936 | (33,816) | | Income Tax Expense | 1,260 | 48,567 | 19,368 | (19,076) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (87,333) | (782,551) | (1,432) | (14,740) | | | Non-recurring Events | | Discontinued Operations | (4,415) | (46,351) | (67,293) | (8,423) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (91,748) | (828,902) | (68,725) | (23,163) | | Preferred Stock And Other Adjustments | 369 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($91,379) | ($828,902) | ($68,725) | ($23,163) |
|
0.45% Nasdaq 
0.20%
Income Statement
